Dalton Investments LLC - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 86 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q1 2020. The put-call ratio across all filers is 0.18 and the average weighting 1.1%.

Quarter-by-quarter ownership
Dalton Investments LLC ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q4 2019$1,810,000
-50.7%
15,551
-51.5%
1.14%
-50.7%
Q3 2019$3,669,000
-59.0%
32,051
-65.8%
2.32%
-42.9%
Q2 2019$8,944,000
-13.9%
93,851
-17.6%
4.06%
-10.5%
Q1 2019$10,389,000
+81.6%
113,851
+51.1%
4.54%
+47.4%
Q4 2018$5,720,000
+31.1%
75,351
+38.1%
3.08%
+50.6%
Q3 2018$4,364,00054,5512.04%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q1 2020
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 131,657$13,077,0005.92%
Point72 Hong Kong Ltd 103,797$10,310,0003.49%
York Capital Management Global Advisors, LLC 827,738$82,219,0002.00%
Parametrica Management Ltd 3,889$386,0001.83%
Athos Capital Ltd 35,266$3,503,0001.19%
Hillhouse Capital Management 618,391$61,425,0001.05%
JUPITER ASSET MANAGEMENT LTD 502,812$49,940,0000.73%
Black Creek Investment Management Inc. 240,232$23,862,0000.73%
COMGEST GLOBAL INVESTORS S.A.S. 243,652$24,202,0000.54%
Temasek Holdings (Private) Ltd 990,000$98,337,0000.52%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders